arrow
S

Sohei Satoi

Kansai Medical University
H指数:50
被引数:8,992

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term impact of acute pancreatitis on patients’ quality of life: a multi-center prospective study in Japan

急性胰腺炎对患者生活质量的长远影响:一项日本的 multicenter 前瞻性研究

2026-08-230
PRE
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model

胰腺导管腺癌术后复发或转移切除后的生存影响:基于时间依赖性Cox回归模型的分析

2026-01-010
PRE
Aso Visual Abstract: Comparison between Neoadjuvant Chemoradiotherapy and Chemotherapy for Patients with Resectable Pancreatic Cancer

AsO 视觉摘要:可切除胰腺癌患者新辅助放化疗与化疗的比较

2025-10-230
PRE
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer

粪便双歧杆菌(Fecal Bifidobacterium)是胰腺癌新辅助化疗后术后复发的预测指标。

2025-10-010
OAAI
Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: A Multicenter National Cohort Study

同步性肝寡转移的胰腺癌患者在接受特定条件下的切除术后显示出显著的长生存获益:一项多中心国家队列研究

2025-07-130
OAAI
Clinical importance of suspicious for malignancy compared to positive for malignancy in peritoneal cytology for surgically resected pancreatic cancer

与手术切除的胰腺癌腹腔细胞学中的“阳性恶性”相比,“可疑恶性”的临床重要性

2025-05-240
OA
Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement

全球范围内关于胰腺颈体部癌伴门-肠系膜静脉受侵的 surgeons 偏好与当前实践的调查

HPB
IF2.4
2025-03-150
PRE
Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma

根据糖类抗原19-9水平改变化疗方案的新辅助治疗可切除/临界可切除胰腺导管腺癌

2024-10-210
PRE
Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria
2024-10-012
OAAI
Optimal treatment strategy for patients with pancreatic cancer having positive peritoneal cytology: A nationwide multicenter retrospective cohort study supervised by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

腹膜细胞学阳性的胰腺癌患者的最佳治疗策略: 一项由日本肝胆胰外科学会监督的全国性多中心回顾性队列研究

2024-09-240
OAAI
Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition
2024-07-297
OAAI
Development of a nomogram to predict survival in advanced biliary tract cancer

预测晚期胆道癌生存率的列线图的开发

2023-12-060
OAAI